Back to Dashboard








Eli Lilly and Company (LLY)
Real-time intraday values
Market Overview
From:
To:
LLY Intraday
No data available
SymbolLLY
IPO DateJun 1, 1972
CEOMr. David A. Ricks
Full Time Employees50k
SectorHealthcare
IndustryDrug Manufacturers - General
CountryUnited States
ExchangeNYSE
Eli Lilly and Company discovers, develops, manufactures, and markets human pharmaceutical products in the United States, Europe, China, Japan, and internationally. The company offers cardiometabolic health products, including Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, Humulin U-500 for diabetes; Jardiance, Mounjaro, and Trulicity for type 2 diabetes; and Zepbound for obesity. It also provides oncology products, such as Cyramza for the second-line treatment of gastric cancer or gastro-esophageal junction adenocarcinoma; Erbitux for colorectal cancers and head and neck cancers; Inluriyo for breast cancer; Jaypirca for chronic lymphocytic leukemia or small lymphocytic lymphoma; Retevmo for the treatment of metastatic NSCLC; TYVYT for classic hodgkin's lymphoma; and Verzenio for breast cancer. In addition, the company offers immunology products, which include Ebglyss; Olumiant; Omvoh; and Taltz. Further, it provides Emgality for migraine prevention and episodic cluster headache; and Kisubla for symptomatic Alzheimer's disease. The company has collaborations with Boehringer Ingelheim Pharmaceuticals, Inc. for the Jardiance product family; and F. Hoffmann-La Roche Ltd and Genentech, Inc. for lebrikizumab, as well as license agreements with Almirall, S.A. for Ebglyss; and Chugai Pharmaceutical Co., Ltd for orforglipron; strategic collaboration with Ascidian Therapeutics for development of therapies for undisclosed monogenic kidney diseases; BioArctic AB (publ) for new treatment; QurCan Therapeutics Inc for development of PLNP-enabled genetic medicine therapeutics for the treatment of central nervous system and peripheral nervous system; and Abbisko Therapeutics for discovery and development of medicines across multiple targets. The company was founded in 1876 and is headquartered in Indianapolis, Indiana.
Performance
| Period | Return % | Value Change |
|---|---|---|
| 1 Day | -0.21% | -2.79 US$ |
| 5 Days | -6.59% | -95.17 US$ |
| 1 Month | +6.11% | +77.58 US$ |
| 6 Months | +26.60% | +283.33 US$ |
Analyzing Market with AI
Evaluating the last 30 days of history and fundamental metrics of LLY...
Key Statistics
Market Cap
1.20T
P/E Ratio
43.85
Div Yield
0.51%
52W High
$1475.25
52W Low
$850.51
Analyst Consensus
ConsensusBuy
Bullish2580.6%
Neutral412.9%
Bearish26.5%
52W Analyst Price Targets
Min Target
$940.00
$940.00
Max Target
$1700.00
$1700.00
Current$1348.33
Avg Target$1470.06
Analyst Recommendations
Target Price:$1470.06($940.00 - $1700.00)
Looking for more stocks? Explore them in the screener
Community Thoughts
Share your analysis and sentiment on LLY
Join the community to share your analysis
Latest News for LLY

Eli Lilly (LLY) After ObesityWeek Is The Stock Still Undervalued
Simply Wall St.•Nov 20, 2026, 08:13 PM

What Does Eli Lilly Offer That Merck Does Not?
Trefis•Nov 20, 2026, 04:59 PM

AbbVie vs. Eli Lilly: Which Healthcare Stock Is a Better Buy for 2027?
Motley Fool•Nov 20, 2026, 04:20 PM
A $4.7 Billion Fund Just Bought These 3 Stocks
TIKR•Nov 20, 2026, 02:58 PM

Cathie Wood Sold Nvidia and Bought $78 Million of Anthropic at IPO
24/7 Wall St.•Nov 20, 2026, 02:52 PM

Should You Buy Bristol Myers Squibb Stock At Today's Discount?
Trefis•Nov 20, 2026, 02:51 PM

Lilly vs. Pfizer: Which Drugmaker Has Stronger Growth Prospects?
Zacks•Nov 20, 2026, 02:39 PM

Big Pharma, with eye on Anthropic, says AI is shrinking drug discovery timelines
Reuters•Nov 20, 2026, 11:09 AM
iShares U.S. Healthcare ETF (IYH) Sells $17.4 Million of Eli Lilly on Wednesday
GuruFocus.com•Nov 20, 2026, 11:05 AM
Invesco S&P 500 Equal Weight (RSP) Sells $0.4 Million of NVR on Nov. 18
GuruFocus.com•Nov 20, 2026, 11:05 AM